Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Bone Biologics Corp. (BBLG) had Operating Cash Flow per Share of $-2.48 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-0.74M |
|
-- |
|
-- |
|
$0.75M |
|
$-0.75M |
|
$0.01M |
|
$-0.74M |
|
$-0.74M |
|
$-0.74M |
|
$-0.74M |
|
$-0.74M |
|
$-0.74M |
|
$-0.75M |
|
$-0.75M |
|
0.56M |
|
0.56M |
|
$-1.33 |
|
$-1.33 |
|
| Balance Sheet Financials | |
$7.00M |
|
-- |
|
-- |
|
$7.00M |
|
$0.41M |
|
-- |
|
-- |
|
$0.41M |
|
$6.60M |
|
$6.60M |
|
$6.60M |
|
1.69M |
|
| Cash Flow Statement Financials | |
$-1.39M |
|
-- |
|
$4.70M |
|
$3.33M |
|
$6.64M |
|
$3.32M |
|
$0.12M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
17.24 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.39M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-11.23% |
|
-11.23% |
|
-10.58% |
|
-11.23% |
|
$3.91 |
|
$-2.48 |
|
|
Operating Cash Flow per Share |
$-2.48 |